Determinants of antipsychotic response in schizophrenia: implications for practice and future clinical trials
July 2024 Update: A new study has found that Ozempic and Wegovy users face an almost 8-fold increased risk of developing vision loss side effects , particularly from a condition called non-arteritic anterior ischemic optic neuropathy (NAION), which can cause cause sudden changes in vision and may lead to blindness
This is why Wegovy (semaglutide for weight loss) is not covered despite Ozempic (same drug for diabetes) being covered
* Schedule your appointment directly on Dr
Key takeaways MeAgain is the GLP-1 dose tracker app that keeps dose timing, shot or pill reminders, injection sites, dose changes, notes if a dose was late or missed, side effects, food, weight, and medication-level context on one timeline
The Meteoric Rise of GLP-1 Utilization The impact of GLP-1s on Medicare spending is already remarkable